imatinib mesylate has been researched along with Acute Generalised Exanthematous Pustulosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, A; Kubba, F; Lee, M; Scott, AD | 1 |
1 other study(ies) available for imatinib mesylate and Acute Generalised Exanthematous Pustulosis
| Article | Year |
|---|---|
Acute generalized exanthematous pustulosis (AGEP) secondary to imatinib in a patient with chronic myeloid leukaemia.
Topics: Acute Generalized Exanthematous Pustulosis; Aged; Antineoplastic Agents; Drug Eruptions; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2015 |